Opens in a new tab

Plant-e Knowledge v Arkyne Technologies (CFI, 22 November 2024)

Date22 November 2024
CourtCFI
DivisionThe Hague (NL) Local Division
Type of actionInfringement Action
Registry referenceACT_549536/2023 · ORD_598516/2023
PartiesPlant-e B.V., Plant-e Knowledge B.V. v. Arkyne Technologies S.L.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In a decision of 22 November 2024 on the infringement action brought by Plant-e Knowledge and Plant-e and the counterclaim for revocation filed by Arkyne Technologies (“Bioo”) (UPC_CFI_239/2023, ACT_549536/2023 and CC_588768/2023), The Hague Local Division upheld EP 2 137 782, which concerns a microbial fuel cell fed by a living plant, and found method claim 11 infringed: by equivalence by the Bioo Panel and Bioo Bench, and literally by the Bioo Ed. The decision is of practical interest on two counts: it sets out a four-question test for equivalence, and it confirms that the Court may itself settle the wording of the recall letter to customers and of the notice to be posted on the infringer’s website.

Facts and procedure

Bioo, a Barcelona start-up, held a non-exclusive licence agreed on 3 August 2018, which it terminated with effect from 29 March 2019 (paragraphs 16 and 17). Plant-e sued for infringement of claim 11 and claims 12 to 16, Bioo counterclaimed for revocation. The language of the proceedings was changed from Dutch to English by an order of 4 October 2023. The oral hearing took place on 30 September 2024.

The applicable law

Validity was examined under Articles 54, 56, 83, 87, 123(2) and 138(1)(c) EPC. As the UPCA contains no provision on equivalence, the Division relied on Article 2 of the Protocol on the Interpretation of Article 69 EPC (paragraph 86). Remedies fell under Articles 25, 26, 63, 64, 67 and 80 UPCA, Article 64 being read in light of Article 10 of Directive 2004/48 (paragraphs 105 to 111).

Question

Does a device that places the plant and its roots in a compartment separate from the anode compartment, while allowing excreted organic matter to reach the anode, use the claimed method by equivalence, and may the Court prescribe the wording of recall measures?

Decision

The patent was valid: priority was validly claimed, there was no added matter, claim 11 was novel over Tender, inventive over every combination relied on since nothing prompted the addition of a living plant to a microbial fuel cell, and sufficiently disclosed (paragraphs 41 to 60). The Bioo Panel did not literally meet feature 11.6, as the roots were kept out of the anode compartment (paragraphs 82 to 84). For equivalence, absent any applicable source and as both parties proposed, the Division adopted a test drawn from national practice: technical equivalence, protection proportionate to the patentee’s contribution, legal certainty for third parties, and novelty and inventiveness of the accused embodiment (paragraph 88). All four were met: the plant supplied organic matter that reached the anode and the device worked in the same way, the additional compartment making no difference (paragraphs 89 to 101). Supplying the products to third parties was indirect infringement under Article 26 UPCA (paragraphs 102 and 103).

The Division granted an injunction for the Benelux, France, Germany and Italy, and ordered recall and destruction of products sold to professional customers, save those already planted in the ground, information and a notice on Bioo’s homepage for one month (paragraphs 105 to 111). It rejected the objection that Article 64 did not allow it to impose the wording of the recall letter: a text settled by the Court avoids ambiguous messages and makes the recall effective (paragraph 108). Penalty payments were capped at EUR 200,000, interim damages were reduced from EUR 100,000 to EUR 35,000, the final amount being left to separate proceedings, and costs were awarded against Bioo up to the ceilings (EUR 56,000 for the infringement action, EUR 112,000 for the counterclaim). The decision is enforceable without security (paragraphs 112 to 116).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts. 20, 24, 25, 26, 34, 63, 64, 67, 69 and 80
Rules of Procedure
Rules 104, 105.5, 150.2, 190, 262.2, 323 and 370.6
European Patent Convention
Arts. 54, 56, 69, 83, 87, 123(2) and 138(1)(c), Protocol on the Interpretation of Article 69, Art. 2
Directive 2004/48/EC
Art. 10
Case law cited
Court of Appeal, 11 March 2024, NanoString v 10x Genomics, Munich Central Division, 16 July 2024, Sanofi v Amgen, The Hague Local Division, 18 June 2024, Abbott v Sibio (UPC_CFI_131/2024).

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Patent infringement action.

Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Infringement Action
Outcome (Dhenne Avocats summary)
La division locale de La Haye juge valable le brevet EP 2 137 782 et retient la contrefaçon de la revendication 11, par équivalence pour le Bioo Panel et le Bioo Bench et littéralement pour le Bioo Ed, avec interdiction, rappel au texte fixé par la juridiction et provision de 35 000 euros.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

  • EP 2 137 782 mentioned in: summary of the decision, Dhenne Avocats analysis Follow this patent

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 137 782
Device and method for converting light energy into electrical energy
recorded proprietor: Plant-E Knowledge BV
Patent at issue according to the summary or official headnote
Also mentioned in 8 other decision(s): Arkyne Technologies v Plant-e Knowledge (CoA, 23 June 2025) · Plant-e Knowledge v Arkyne (CFI, ORD_27758/2024, 15 May 2024) · Plant-e Knowledge v Arkyne Technologies (CFI, 4 March 2024) · Plant-e Knowledge v Arkyne Technologies (CFI, 15 February 2024) · Plant-e Knowledge v Arkyne Technologies (CFI, 13 February 2024) · Plant-e Knowledge v Arkyne Technologies (CFI, 17 January 2024) · Plant-e Knowledge v Arkyne Technologies (CFI, 18 October 2023) · Plant-e Knowledge v Arkyne Technologies (CFI, 3 August 2023)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: summary of the decision, Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.